NO20004631L - Forbindelser og fremgangsmÕter for terapi og diagnose av lungekreft - Google Patents

Forbindelser og fremgangsmÕter for terapi og diagnose av lungekreft

Info

Publication number
NO20004631L
NO20004631L NO20004631A NO20004631A NO20004631L NO 20004631 L NO20004631 L NO 20004631L NO 20004631 A NO20004631 A NO 20004631A NO 20004631 A NO20004631 A NO 20004631A NO 20004631 L NO20004631 L NO 20004631L
Authority
NO
Norway
Prior art keywords
lung cancer
compounds
diagnosis
methods
therapy
Prior art date
Application number
NO20004631A
Other languages
English (en)
Other versions
NO20004631D0 (no
Inventor
Steven G Reed
Tongtong Wang
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/040,984 external-priority patent/US6210883B1/en
Priority claimed from US09/123,912 external-priority patent/US6312695B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of NO20004631D0 publication Critical patent/NO20004631D0/no
Publication of NO20004631L publication Critical patent/NO20004631L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Det tilveiebringes forbindelser og fremgangsmåter for behandling og diagnostisering av lungekreft. Forbindelsene inkluderer polypeptider som inneholder i det minste en del av et lungetumorprotein. Vaksiner og farmasøytiske blandinger for immunterapi av lungekreft, omfattende slike polypeptider eller DNA-molekyler som koder for slike polypeptider, tilveiebringes også, sammen med DNA-molekyler for fremstilling av polypeptidene.
NO20004631A 1998-03-18 2000-09-15 Forbindelser og fremgangsmÕter for terapi og diagnose av lungekreft NO20004631L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4080298A 1998-03-18 1998-03-18
US09/040,984 US6210883B1 (en) 1998-03-18 1998-03-18 Compounds and methods for diagnosis of lung cancer
US12393398A 1998-07-27 1998-07-27
US09/123,912 US6312695B1 (en) 1998-03-18 1998-07-27 Compounds and methods for therapy of lung cancer
PCT/US1999/005798 WO1999047674A2 (en) 1998-03-18 1999-03-17 Compounds and methods for therapy and diagnosis of lung cancer

Publications (2)

Publication Number Publication Date
NO20004631D0 NO20004631D0 (no) 2000-09-15
NO20004631L true NO20004631L (no) 2000-11-15

Family

ID=27488687

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004631A NO20004631L (no) 1998-03-18 2000-09-15 Forbindelser og fremgangsmÕter for terapi og diagnose av lungekreft

Country Status (13)

Country Link
EP (1) EP1064372B1 (no)
JP (1) JP2002533056A (no)
CN (1) CN1299414A (no)
AT (1) ATE345387T1 (no)
AU (1) AU3094999A (no)
BR (1) BR9908823A (no)
CA (1) CA2323093A1 (no)
DE (1) DE69933998T2 (no)
ES (1) ES2277432T3 (no)
IL (1) IL138330A0 (no)
NO (1) NO20004631L (no)
NZ (1) NZ506699A (no)
WO (1) WO1999047674A2 (no)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US7338937B2 (en) * 1997-11-17 2008-03-04 Cornell Research Foundation, Inc. Calcium-activated chloride channel proteins and their use in anti-metastatic therapy
WO1999040183A1 (en) 1998-02-06 1999-08-12 Human Genome Sciences, Inc. Human serine protease and serpin polypeptides
US6660838B1 (en) 1998-03-18 2003-12-09 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6482597B1 (en) 1999-12-17 2002-11-19 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6960570B2 (en) 1998-03-18 2005-11-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6821518B1 (en) 1998-03-18 2004-11-23 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US7049063B2 (en) 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
US6426072B1 (en) 2000-08-02 2002-07-30 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7258860B2 (en) 1998-03-18 2007-08-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6312695B1 (en) 1998-03-18 2001-11-06 Corixa Corporation Compounds and methods for therapy of lung cancer
US6737514B1 (en) 1998-12-22 2004-05-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6706262B1 (en) 1998-03-18 2004-03-16 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6696247B2 (en) 1998-03-18 2004-02-24 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6531315B1 (en) 1998-03-18 2003-03-11 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7579160B2 (en) 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
US6518256B1 (en) 1998-03-18 2003-02-11 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US20040235072A1 (en) * 1998-03-18 2004-11-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
PT1847607E (pt) 1998-03-27 2011-08-25 Otsuka Pharma Co Ltd Anticorpos contra a proteína p51
DE19822985C1 (de) * 1998-05-25 2000-01-13 Fraunhofer Ges Forschung Tumorsuppressorgene der p53-Familie
US6528054B1 (en) * 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
AU3316600A (en) 1999-02-22 2000-09-21 Torben F. Orntoft Gene expression in bladder tumors
HK1049848A1 (zh) * 1999-04-02 2003-05-30 科里克萨有限公司 用於治療和診斷肺癌的化合物和方法
DE19924199A1 (de) * 1999-05-27 2000-11-30 Boehringer Ingelheim Int Tumorassoziiertes Antigen
WO2001016324A2 (en) * 1999-08-31 2001-03-08 Board Of Regents, The University Of Texas System Methods and compositions of a novel serine protease inhibitor
US6992170B2 (en) 1999-10-15 2006-01-31 Curagen Corporation Polypeptides and polynucleotides homologous to thymosin, ephrin a receptors, and fibromodulin
US6855806B1 (en) 1999-10-15 2005-02-15 Curagen Corporation Thymosin beta 10-like proteins and nucleic acids encoding same
AU1204301A (en) * 1999-10-15 2001-04-30 Curagen Corporation Novel polypeptides and polynucleotides encoding same
KR20020064901A (ko) * 1999-11-24 2002-08-10 다케다 야쿠힌 고교 가부시키가이샤 질환관련 유전자의 용도
CA2410624A1 (en) * 2000-05-26 2001-12-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
WO2001096389A2 (en) * 2000-06-09 2001-12-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
EP1356093A2 (en) 2000-06-21 2003-10-29 Hitachi Chemical Co., Ltd. Gene markers for lung cancer
EP1961819A3 (en) * 2000-06-28 2008-11-12 Corixa Corporation Composition and methods for the therapy and diagnosis of lung cancer
EP1366157A2 (en) * 2000-06-29 2003-12-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7141365B2 (en) 2001-05-18 2006-11-28 Syntex (U.S.A.) Llc Methods for diagnosing a mucin production associated disease condition
EP1757693A3 (en) 2001-08-24 2007-05-09 Hisamitsu Pharmaceutical Co. Inc. Nucleic acids showing difference in expression between hepatoblastoma and normal liver
ATE518884T1 (de) 2002-05-01 2011-08-15 Human Genome Sciences Inc Spezifisch an chemokin beta-4 bindende antikörper
EP4043552A1 (en) * 2009-06-11 2022-08-17 Minerva Biotechnologies Corporation Methods for culturing stem and progenitor cells
SG191716A1 (en) 2010-11-19 2013-08-30 Toshio Imai Neutralizing anti-ccl20 antibodies
CN117417938A (zh) * 2022-01-31 2024-01-19 奥明(杭州)生物医药有限公司 一种环状rna分子及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor

Also Published As

Publication number Publication date
ATE345387T1 (de) 2006-12-15
DE69933998D1 (de) 2006-12-28
BR9908823A (pt) 2000-11-21
JP2002533056A (ja) 2002-10-08
NZ506699A (en) 2003-12-19
EP1064372A2 (en) 2001-01-03
DE69933998T2 (de) 2007-10-04
EP1064372B1 (en) 2006-11-15
CN1299414A (zh) 2001-06-13
ES2277432T3 (es) 2007-07-01
NO20004631D0 (no) 2000-09-15
AU3094999A (en) 1999-10-11
WO1999047674A3 (en) 2000-01-20
WO1999047674A2 (en) 1999-09-23
IL138330A0 (en) 2001-10-31
CA2323093A1 (en) 1999-09-23

Similar Documents

Publication Publication Date Title
NO20004631D0 (no) Forbindelser og fremgangsmÕter for terapi og diagnose av lungekreft
PL354348A1 (en) Compounds and methods for therapy and diagnosis of lung cancer
WO1999033869A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
WO1999038973A3 (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
TW581808B (en) Compounds for immunotherapy of prostate cancer and methods for their use
WO1998037093A3 (en) Compounds for immunotherapy of prostate cancer and methods for their use
NZ516381A (en) Lung tumor proteins in the therapy and diagnosis of lung cancer
HUP0203035A2 (hu) Prosztatarák terápiájára és diagnózisára alkalmas vegyületek és eljárások
IL153996A0 (en) Polypeptides containing at least a portion of an ovarian carcinoma protein, polynucleotides encoding the same and pharmaceutical compositions containing the same
WO1997025426A3 (en) Compositions and methods for the treatment and diagnosis of breast cancer
IL153052A0 (en) Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
HUP0203968A2 (hu) Készítmények és eljárások prosztatarák terápiájára és diagnózisára
AR006250A1 (es) Compuestos y metodos para la inmunoterapia e inmunodiagnostico del cancer prostatico
WO1998045328A3 (en) Compositions and methods for the treatment and diagnosis of breast cancer
WO2000061756A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
WO2001018046A3 (en) Ovarian tumor sequences and methods of use therefor
ATE514780T1 (de) Zusammensetzungen für die therapie und diagnose von brustkrebs und verwendung davon
WO1999018210A3 (en) Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
WO1999037775A3 (en) Compositions and methods for detecting and treating breast cancer
ATE435284T1 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
WO2004015390A3 (en) Lung cancer target proteins and use thereof
EP1792988A3 (en) Compounds and methods for therapy and diagnosis of lung cancer
WO2003042700A3 (en) Breast cancer associated polypeptide
CO5050254A1 (es) Compuestos para el tratamiento y diagnostico del cancer de pulmon
CO5241295A1 (es) Compuestos para inmunoterapia y para el diagnostico del can- cer de mama y metodos para su utilizacion

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application